Long-read, whole-genome sequencing and chemotherapy response of two patient-derived organoids from a TP53- and KRAS-mutant ovarian carcinoma
Jae Rim Wendt, Kristin M. Adams, Ryan Moreno, Md Shahadat Hossan, Austin Stram, Ethan Samuel Lin, Lauren Kersten, Jeremy D. Kratz, Madhuchhanda Roy, Stephanie M. McGregor, Jessica D. Lang
This paper describes two patient-derived organoids from a TP53- and KRAS-mutant ovarian carcinoma, showing differential chemotherapy response and using long-read sequencing to characterize structural variants and methylation differences.
bioRxiv · Jul 10, 2026 · PreprintCancer Biology